Skip to content
10-Q

Quarterly Report

TETRALOGIC PHARMACEUTICALS CORP

0001558370-16-005275

← back to feed
Filed
May 4, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Apr 28, 2016 24.77M sh
Shares Diluted Q1 2016 · Mar 31, 2016 24.77M sh
Shares Diluted Q1 2016 · Mar 31, 2015 22.86M sh
Cash And Equivalents Q1 2016 · Mar 31, 2016 $14.54M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $15.3M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $16.97M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $13.07M
Stockholders Equity Q1 2016 · Mar 31, 2016 −$16.06M
Stockholders Equity Q1 2016 · Dec 31, 2015 −$5.94M
Current Liabilities Q1 2016 · Mar 31, 2016 $4.97M
Current Liabilities Q1 2016 · Dec 31, 2015 $3.66M
Total Liabilities Q1 2016 · Mar 31, 2016 $73.66M
Total Liabilities Q1 2016 · Dec 31, 2015 $69.96M
Current Assets Q1 2016 · Mar 31, 2016 $15.99M
Current Assets Q1 2016 · Dec 31, 2015 $21.97M
Total Assets Q1 2016 · Mar 31, 2016 $57.6M
Total Assets Q1 2016 · Dec 31, 2015 $64.02M
Eps Diluted Q1 2016 · Mar 31, 2016 −$0.45
Eps Diluted Q1 2016 · Mar 31, 2015 −$0.56
Eps Basic Q1 2016 · Mar 31, 2016 −$0.45
Eps Basic Q1 2016 · Mar 31, 2015 −$0.56
Sga Expense Q1 2016 · Mar 31, 2016 $2.97M
Sga Expense Q1 2016 · Mar 31, 2015 $3.14M
Rd Expense Q1 2016 · Mar 31, 2016 $3.3M
Rd Expense Q1 2016 · Mar 31, 2015 $6.45M
Net Income Q1 2016 · Mar 31, 2016 −$11.07M
Net Income Q1 2016 · Mar 31, 2015 −$12.68M
Operating Income Q1 2016 · Mar 31, 2016 −$9.34M
Operating Income Q1 2016 · Mar 31, 2015 −$10.63M
Revenue Q1 2016 · Mar 31, 2016 $0
Capex Q1 2016 · Mar 31, 2015 $34.49K